TREM2 Agonism with CX3CR1 Antagonism for Microglial Homeostasis

Neuroinflammation Biomarker Panel for Early AD Detection: Therapeutic Hypotheses

1. TYROBP Causal Network Inhibition for Microglial Repolarization

Description: TYROBP (TYRO protein tyrosine kinase-binding protein) functions as the obligate signaling adaptor for TREM2 and other activation receptors controlling microglial homeostasis. Genetic network analysis reveals TYROBP expression strongly correlates with disease progression, and selective inhibition of TYROBP-driven pro-inflammatory modules—while preserving homeostatic TREM2 signaling—may repolarize microglia toward a neur

Critical Evaluation of Neuroinflammation Hypotheses for Early AD Detection

Hypothesis 1: TYROBP Causal Network Inhibition for Microglial Repolarization

Specific Weaknesses in the Evidence

Therapeutic Intractability of TYROBP as a Scaffold Protein
TYROBP (DAP12) functions as an obligate transmembrane signaling adaptor with no intrinsic enzymatic activity. As a scaffold protein, TYROBP lacks obvious druggable pockets for selective negative allosteric modulation. The proposed strategy of selectively disrupting "inflammatory cascades downstream of TYROBP without blocking tro

Neuroinflammation Biomarker Panel for Early AD: Practical Drug Development Assessment

Executive Summary

The hypotheses span a wide spectrum of target tractability, from clinically advanced TREM2 agonists to fundamentally undruggable scaffold proteins. The most significant pattern emerging from practical analysis: neuroinflammation targets face a persistent translational gap, with most preclinical successes failing in human studies—often due to species pharmacology differences, inadequate CNS penetration, or timing/context-dependency that mouse models cannot capture.

Below I provi